Observational studyBMJ open2015
Lung cancer treatment rates and the role of the lung cancer nurse specialist: a qualitative study.
Observational study in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The Efficacy and Safety of a Personalized Protocol Designed to Balance Hemoglobin Levels in Hemodialysis Patients as Led by Nephrology Clinical Nurse Specialists: An Intervention Study.Healthcare (Basel, Switzerland) · 2025Article
- Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.Respirology (Carlton, Vic.) · 2024Article
- The Oncology Clinical Nurse Specialist: A Rapid Review of Implementation Models and Barriers around the World.Current oncology (Toronto, Ont.) · 2023Review
- Persisting Gaps in Optimal Care of Stage III Non-small Cell Lung Cancer: An Australian Patterns of Care Analysis.The oncologist · 2023Article
- Registered nurses' views on consideration of patient perspectives during multidisciplinary team meetings in cancer care.BMC nursing · 2022Article
- Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021.BMJ open respiratory research · 2022Article
- Article
- Factors influencing the delivery of cancer pathways: a summary of the literature.Journal of health organization and management · 2021Article
- Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.The oncologist · 2021Review
- Impact of having a certified nurse specialist in critical care nursing as head nurse on ICU patient outcomes.PloS one · 2020Article
- Patients' experience of lung cancer care coordination: a quantitative exploration.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Article
- Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience.BMJ open respiratory research · 2019Article
- Relevance of a specialised nurse in thoracic surgery.Journal of thoracic disease · 2018Review
- Article
- The lung cancer nurse role in the management of paraneoplastic syndromes in lung cancer.Translational lung cancer research · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis qualitative study examines how the Lung Cancer Nurse Specialist (LCNS) role operates and why they may be able to increase access to treatment.
setting4 Hospital NHS Foundation Trusts in England.
designA multiple case study design using semistructured interviews, observation and Framework Analysis techniques.
participantsFour LCNSs, comprised the 'cases'. Twenty four clinicians who worked with the LCNS participated in individual interviews. Six LCNSs took part in a group interview and 60 lung cancer multidisciplinary team (MDT) members and coordinators were observed in the MDT meeting.
resultsThe LCNS is crucial within the MDT and can act as a catalyst to patient access to treatment. The study identified the clinical activity (assessment, managing symptoms, psychological support and information provision) and role characteristics that can facilitate treatment access. These characteristics are the LCNS's presence across the patient pathway, acting as the 'hub' of the MDT, maintaining a holistic patient focus and working to an advanced level of practice. The findings indicate how factors may have a cumulative impact on treatment access.
conclusionsIf UK patient with lung cancer survival rates are to improve in line with comparable countries, we need to employ every advantage. This study demonstrates how the LCNS role may open doors to positive patient outcomes, including treatment. Further research is required to explore patients' experiences, decision-making and attitudes to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.